Effect of bleomycin on benign and malignant cutaneous tumours.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001003:Anal Canal; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001415:Back; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001940:Breast; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002610:Cheek; D002680:Chin; D003218:Condylomata Acuminata / Q000188:drug therapy*; D004273:DNA, Neoplasm; D004423:Ear; D005260:Female; D006225:Hand; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy*; D013909:Thorax; D014860:Warts / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D004273:DNA, Neoplasm; D001761:Bleomycin